The PharmaEssentia Innovation Research Center (PIRC) will advance the company’s diverse pipeline and research footprint in the U.S., driving job creation
The centre will initially employ 170 engineers, bringing the total number of Boston Scientific’s R&D employees in India to more than 300
The transaction is anticipated to close in the first quarter of 2022
Advancing toward Phase 2a evaluation in chemotherapy-related pain, a condition with no approved treatments and potential for FDA Fast Track designation
Telangana aims to increase the value of the Life Sciences economy from US$ 80 billion to US$ 250 billion by 2030
82,514 sq ft facility to host up to 15 biotech companies, fueling the development of next-generation medicines
Agency initiates safety label change and notifies physicians of possible link
Combination creates a leading, next generation claims operating system for payers, with end-to-end AI capabilities for claims, payments, care & utilization management, payment integrity, and member engagement, serving 115+ health plans
The AI system was tested on digital slides from breast, colon, stomach, and esophageal cancer cases
Aman holds a bachelor’s degree in economics from Boston University and an MBA from Columbia University, New York
Subscribe To Our Newsletter & Stay Updated
